| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |